India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like Infographic: IIoT Blueprint: Choosing the Right Solution December 18, 2019 MonarchFx partners with NFI to create Rapid Deployment MonarchFx Center in California January 12, 2018 Industry 4.0 Reaches Cutting Tools February 22, 2019
MonarchFx partners with NFI to create Rapid Deployment MonarchFx Center in California January 12, 2018